Gene therapy for cancer
- 1 May 1994
- journal article
- review article
- Published by Elsevier in Trends in Genetics
- Vol. 10 (5) , 174-178
- https://doi.org/10.1016/0168-9525(94)90095-7
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Clinical Implications of the p53 Tumor-Suppressor GeneNew England Journal of Medicine, 1993
- Phase I Study of Cytokine-Gene Modified Autologous Neuroblastoma Cells for Treatment of Relapse/Refractory NeuroblastomaHuman Gene Therapy, 1992
- A Pilot Study of Immunization with HLA-A2 Matched Allogeneic Melanoma Cells That Secrete Interleukin-2 in Patients with Metastatic MelanomaHuman Gene Therapy, 1992
- A Pilot Study of Immunization with Interleukin-2 Secreting Allogeneic HLA-A2 Matched Renal Cell Carcinoma Cells in Patients with Advanced Renal Cell CarcinomaHuman Gene Therapy, 1992
- Immunotherapy of Malignancy by In Vivo Gene Transfer into TumorsHuman Gene Therapy, 1992
- Selection of Drug-Resistant Bone Marrow Cells in Vivo After Retroviral Transfer of Human MDR 1Science, 1992
- Immunization of Cancer Patients Using Autologous Cancer Cells Modified by Insertion of the Gene for Interleukin-2 (National Institutes of Health)Human Gene Therapy, 1992
- Points to Consider Response with Clinical Protocol, July 6, 1990Human Gene Therapy, 1990
- Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor responseCell, 1990
- Murine interleukin-4 displays potent anti-tumor activity in vivoCell, 1989